Herbal Medicine Cordyceps sinensis Improves Health-Related Quality of Life in Moderate-to-Severe Asthma

Table 2

AQLQ scores at baseline, immediately following the intervention period, and at the 3-month follow-up assessment.

	Control group ()			Treatment group ()
	Baseline	Postintervention	3-month follow-up	Baseline	Postintervention	3-month follow-up
AQLQ
Activity limitation	5.46; (4.92, 5.92)	5.58; (4.33, 5.92)	5.25; (4.00, 5.67)	5.08; (4.50, 5.67)	5.25; (4.33, 6.17)	5.50; (4.33, 6.17)^ac	2.446	0.014
Asthma symptom	5.78; (4.78, 6.67)	5.89; (5.00, 6.44)	6.05; (5.56, 6.33)^b	5.61; (4.89, 6.33)	6.11; (5.22, 6.67)^a	6.27; (5.33, 6.78)^ac	2.382	0.037
Emotional function	5.50; (5.20, 6.40)	6.20; (3.60, 6.40)	5.80; (5.00, 6.44)	5.40; (4.60, 6.20)	5.70; (4.80, 6.60)	6.10; (5.20, 6.60)^bd	2.667	0.008
Environment stimuli	6.60; (5.60, 7.00)	6.40; (5.60, 6.80)	6.00; (5.00, 6.20)	6.20; (5.40, 7.00)	6.20; (5.20, 7.00)	6.20; (5.00, 7.00)	1.219	0.223
Overall average	5.63; (5.20, 5.91)	5.80; (4.94, 6.06)	5.60; (4.57, 6.20)	5.44; (3.25, 5.50)	5.78; (5.14, 6.51)^a	5.81; (4.80, 6.20)^bc	2.244	0.049

Data are medium (IQR). and versus baseline; and CS group versus control group.